We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAD
11126
DELISTED
B.A.D. ETF
BAD
-325
Closed -$5K
TDSA
11127
DELISTED
Cabana Target Drawdown 5 ETF
TDSA
-260
Closed -$7K
WIZ
11128
DELISTED
Alpha Architect Merlyn.AI Bull-Rider Bear-Fighter ETF
WIZ
-463
Closed -$17K
EQRXW
11129
DELISTED
EQRx, Inc. Warrant
EQRXW
$0 ﹤0.01%
190
-34
-15% -$28
NEWR
11130
CALL
DELISTED
New Relic, Inc.
NEWR
-45,000
Closed -$4.95M
ACER
11131
DELISTED
Acer Therapeutics Inc
ACER
$0 ﹤0.01%
33
+7
+27% +$17
PRPC.WS
11132
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$0 ﹤0.01%
161
-707
-81% -$507
MLPO
11133
DELISTED
Credit Suisse S&P MLP Index ETN
MLPO
$0 ﹤0.01%
4
-5
-56% -$51
ARTEW
11134
DELISTED
Artemis Strategic Investment Corporation Warrant
ARTEW
-999
Closed
MDNA
11135
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
-2,882
Closed -$5K
HEWU
11136
DELISTED
iShares Currency Hedged MSCI United Kingdom ETF
HEWU
-698
Closed -$16K
BODY.WS
11137
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$0 ﹤0.01%
166
EGLX
11138
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$0 ﹤0.01%
1
-6,438
-100% -$17.1K
LTRPB
11139
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
-469
Closed -$8K
SFRWW
11140
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$0 ﹤0.01%
+400
New +$160
SFR
11141
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
-1,542
Closed -$15K
AKU
11142
DELISTED
Akumin Inc
AKU
-1,490
Closed -$3K
NFNT.WS
11143
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$0 ﹤0.01%
+728
New +$318
VHAQ.WS
11144
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$0 ﹤0.01%
1,919
-6,707
-78% -$858
WGRO
11145
DELISTED
WisdomTree U.S. Growth & Momentum Fund
WGRO
-375
Closed -$10K
RVLP
11146
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$0 ﹤0.01%
225
-2,547
-92% -$3.64K
HPLTW
11147
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$0 ﹤0.01%
+330
New +$146
FATH
11148
DELISTED
Fathom Digital Manufacturing Corporation
FATH
-26
Closed -$4K
ADERW
11149
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
-11,552
Closed -$8K
DBTX
11150
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-95
Closed

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.